HonorHealth Research Institute Jan 20 2026 A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new   investigational treatment that targets platelets - rather than traditional clotting proteins - to help reopen blocked blood vessels in the brain . The drug,   BB-031, represents the first new stroke medication in nearly 30 years. Stroke symptoms can include sudden weakness, difficulty speaking, confusion, vision loss, or loss of balance. Stroke is the fourth